Rare diseases
Investigational molecules
Locations
Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark
Region Midtjylland in Aarhus, Denmark specialises in clinical trials of conditions such as Obesity, Plasma cell myeloma, Arteriosclerosis, Overweight, and other specialisations. This site conducts important research.
The Oncology Department at Region Midtjylland conducts studies focused on atherosclerotic cardiovascular disease and the prevention of recurrent ischemic events. Trials aim to test new oral agents that could lower the risk of major adverse cardiovascular events and improve safety for patients already on antiplatelet therapy.
With 64 investigators, the site supports robust cardiovascular research while maintaining patient‑centered care.
In the field of neoplasms, the center evaluates innovative treatment strategies for aggressive retroperitoneal sarcomas, including high‑risk de‑differentiated liposarcoma and leiomyosarcoma. The goal is to determine whether adding chemotherapy before curative‑intent surgery can improve disease‑free survival.
The program reflects the department’s commitment to advancing cancer care through multidisciplinary collaboration.
Clinical trials currently enrolling participants at this site.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
DenmarkA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
DenmarkRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
DenmarkA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
DenmarkA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
DenmarkStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
DenmarkLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
DenmarkA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
DenmarkA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
DenmarkStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
DenmarkStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
DenmarkStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
DenmarkMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
